Secondarily, the focus is on both the rising costs and mandated Rx reporting. A new prescription drug drugs in premium increases, Several solutions being reporting mandate, adopted as helping to identify excessive discussed at this stage are part of the 2021 Consolidated drug pricing due to market government intervention via Appropriations Act, requires concentration, promote generic high-risk pools, leveraged group health plans and health drugs, and address the cost purchasing, or shifting patients insurers in the group and impact of drug manufacturer to Medicare as 80% of large individual markets to report rebates. The Rx and health care employers are concerned that annually certain information spending reporting rule applies current strategies to 昀椀nance about drug and health care to health insurers and ERISA high-price therapies do little to spending to the federal group health plans, whether fully address overall price. government. This includes insured or self-insured. information about health care spending by category, the most frequently dispensed and costliest prescription drugs, and information about rebates paid by the drug manufacturers to plans, issuers, TPAs and PBMs. It also will provide transparency around the impact of complex drug pricing mechanisms, rebates, fees, and other remuneration paid by drug 2 manufacturers on premiums. The data will be used to prepare a publicly available report about prescription drug reimbursements and pricing, and the role of prescription 2023 Benefits Trends: The evolving workplace 80